CytoDyn (CYDY) Payables (2011 - 2026)
CytoDyn (CYDY) reported Payables of $22.8 million for fiscal Q4 2026 (quarter ended May 31, 2026), down 0.7% from $22.96 million a year earlier and down 0.2% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Payables (2011 - 2026) Analysis & Trends
Dating back to fiscal Q4 2011, CytoDyn's Payables record includes 61 quarters.
- Payables has declined for four consecutive fiscal years, with a five-year compound annual growth rate of -19.8% (FY2021 to FY2026).
- By fiscal year, Payables came in at $22.96 million in FY2025 (-36.8%), $36.35 million in FY2024 (-46.7%), $68.14 million in FY2023 (-5.3%) and $71.98 million in FY2022 (+5.0%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Payables since fiscal Q2 2025.
- Year over year, Payables gained in two of the last eight quarters, with an average decline of 28.5%.
- The high point for year-over-year Payables in five years was fiscal Q1 2022 (growth of 203.3%); the low point was fiscal Q1 2025 (a decline of 68.9%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $22.85 million (Q3 2026), $23.26 million (Q2 2026) and $22.82 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | CytoDyn | 288.44 Mn | 288.44 Mn | - | 22.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 22.80 Mn |
| Feb 28, 2026 | 22.85 Mn |
| Nov 30, 2025 | 23.26 Mn |
| Aug 31, 2025 | 22.82 Mn |
| May 31, 2025 | 22.96 Mn |
| Feb 28, 2025 | 23.02 Mn |
| Nov 30, 2024 | 21.78 Mn |
| Aug 31, 2024 | 21.32 Mn |
| May 31, 2024 | 36.35 Mn |
| Feb 29, 2024 | 68.52 Mn |
| Nov 30, 2023 | 68.38 Mn |
| Aug 31, 2023 | 68.48 Mn |
| May 31, 2023 | 68.14 Mn |
| Feb 28, 2023 | 68.12 Mn |
| Nov 30, 2022 | 72.49 Mn |
| Aug 31, 2022 | 73.36 Mn |
| May 31, 2022 | 71.98 Mn |
| Feb 28, 2022 | 66.04 Mn |
| Nov 30, 2021 | 61.49 Mn |
| Aug 31, 2021 | 69.01 Mn |
API Access
CytoDyn Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();